Implant Veterans of Toxic Exposure

McGhan Shells

Home
Action
Alerts
Hayes
Congressional Report
AMT-1
AMT Audit
Fly-In
ASPRS Survey
Bell & Pointer
BI Capsules
BI Chemicals
BI Numbers - Dow
Burson-Marsteller
B-M's Spokesdoctors
Dr. Pierre Blais
Burson - NEW
Cab-O-Sil
CANDO
Capsules
Chemical Adverse
ChemBMS
Children
Chem Soup
Connie Chung
CRS_safety
Dowknew1
Dowknew2
Dowknew3
Dowknew4
Dow Bleed
Dow Disease
Dow Fraud
Dow Migration
Dow Rupture
DC Whines
Dr. Anderson
Explant
Gagged
Gel Reaction
Griffin Bell
Hancock
Harvard-Brigham
HAD
Inflammation
Jenny
Judge Jones Transcript
Kessler
Latissimus
Maryland Informed
McKennon
McGhan-Shells
Poem to Congress
No Evidence
Cole
Norman Cole
Notable People
Scleroderma
SS
Study-Adjuvant
Study-Adjuvant-FDA
Study-Beagle
Study-Dogs
Study NY
Study-Tissue Reaction
Talcott
Testimony
Ultra Sound
Links

MCG000133053

 

McGhan

 

 

 

January 22, 1993

 

Feargal Judge

General Manager

McGhan Limited

Kilbride Industrial Estates

Arklow County Wicklow

Ireland

 

 

Dear Feargal,

 

Enclosed are two reports. The first report is from Valerie Mandrell, revising the package inserts. She has made several changes providing consistency with current McGhan Medical packaging. It is felt that these changes can be incorporated upon the next purchase of inserts and that these changes should not delay market release.

 

The second report is the Technical Report on the Style 177 physical characteristics. In summary, all product passed testing, but just hardly in some instances. The outer lumen shells are on the low end of the specification, therefore, leading to reduced physical characteristics. It is suggested that the outer lumen shell thickness be increased within the present ranges in your future runs.

 

We wish you a great success with this product and I hope to meet you in the homeland” in the near future.

 

Sincerely,

 

 

Patrick O’Leary,  Ph.D.

Manager, Technologies

 

PO:ar

cc:    J. McGhan
J. Barber

Site maintained by Pamela G. Dowd